AtriCure, Inc. (ATRC) Posts Q1 EPS Loss of $0.08
AtriCure, Inc. (NASDAQ: ATRC) reported Q1 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $15.6 million versus the consensus estimate of $15.96 million.